Birth outcomes in women exposed to anticonvulsant drugs

Acta Neurol Scand. 2000 May;101(5):289-94. doi: 10.1034/j.1600-0404.2000.90193a.x.

Abstract

Objectives: To examine the risk of malformations and fetal growth in women treated with anticonvulsant drugs in North Jutland County, Denmark.

Material and methods: All women treated with anticonvulsant drugs in the county were identified in a Pharmaco-Epidemiological Prescription Database and linked to the Danish Medical Birth Registry and the Regional Hospital Discharge Registry.

Results: We identified 235 pregnancies exposed to anticonvulsants around conception and/or during pregnancy as well as 17,259 unexposed pregnancies where the mother had not received any prescription. There was 1 case of neural tube defect among 15 malformations in the exposed cohort. The overall risk of malformations was 2.2 (95% confidence intervals 1.3-3.8). The risk of low birth weight and preterm delivery was 1.5 (95% confidence intervals 0.6-3.7) and 1.6 (95% confidence intervals 1.0-2.5), respectively.

Conclusion: We found an increased risk of congenital malformations and a tendency to growth retardation in children of women exposed to anticonvulsants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Drug-Induced / epidemiology*
  • Adult
  • Anticonvulsants / adverse effects*
  • Epidemiologic Studies
  • Female
  • Humans
  • Incidence
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Obstetric Labor, Premature*
  • Pregnancy
  • Pregnancy Outcome
  • Risk Factors

Substances

  • Anticonvulsants